FDA Inspection 1083568 — Mark E. Magee
The FDA completed an inspection of Mark E. Magee on March 15, 2019 in Lenexa, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 15, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Lenexa, KS (United States)
Additional Details
Clinical Investigator (CI)